When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   Just approved by the FDA last year, this new drugcombines dextromethorphan and bupropion (Wellbutrin). And like esketamine, it works fast. And like esketamine, it works fast. In clinical trials ...

3. FDA Approves First Fast-Acting Drug for Depression That ... - AOL

   www.aol.com/fda-approves-first-fast-acting...

   The FDA approves an oral medication to treat clinical depression: Auvelity from Axsome Therapeutics. ... marking the first new type of medication to be approved for clinical depression in 60 years ...

4. 4 FDA-Approved MAOIs (& 8 of Their Common Interactions)

   www.aol.com/4-fda-approved-maois-8-105700024.html

   Here are some of the current FDA-approved MAOIs for treating depression: Phenelzine. Sold under the brand name Nardil, phenelzine is prescribed to treat depression and anxiety disorders ...

5. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

6. Your Guide to the 6 Most Common Types of Depression ... - AOL

   www.aol.com/6-types-depression-medications...

   Levomilnacipran, sold under the name Fetzima, is a newer SNRI antidepressant. It got an FDA seal of approval in 2009 as an approved treatment for MDD, but it’s not typically prescribed to treat ...

7. Levomilnacipran - Wikipedia

   en.wikipedia.org/wiki/Levomilnacipran

   Levomilnacipran (brand name Fetzima) is an antidepressant which was approved in the United States in 2013 for the treatment of major depressive disorder (MDD) in adults. [5] It is the levorotatory enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin–norepinephrine reuptake inhibitor (SNRI). [8] [9]